Related Experiment Video

Updated: Feb 21, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.3K

[Mesothelioma]

I Tischoff1, A Tannapfel2

  • 1Institut für Pathologie, Ruhr-Universität Bochum am Berufsgenossenschaftlichen Universitätsklinikum Bergmannsheil, Bürkle-de-la-Camp-Platz 1, 44879, Bochum, Deutschland. iris.tischoff@rub.de.

Der Pathologe
|October 8, 2017
PubMed

Insights

Malignant mesotheliomas are rare, aggressive cancers originating in mesothelial cells, often linked to asbestos exposure. Distinguishing them from other conditions, especially reactive mesothelial proliferation, presents a diagnostic challenge.

Area of Science:

  • Oncology
  • Pathology
  • Occupational Health

Background:

  • Malignant mesotheliomas are rare, aggressive tumors originating from mesothelial cells.
  • Most commonly affect the pleura (over 80%), with rarer occurrences in the peritoneum, pericardium, and tunica vaginalis testis.
  • Predominantly affects men over 60, with a significant link to asbestos exposure (54-90% of cases).

Purpose of the Study:

  • To summarize the key characteristics of malignant mesotheliomas.
  • To highlight the etiological role of asbestos exposure.
  • To emphasize the diagnostic challenges, particularly differentiating from reactive mesothelial proliferation.

Main Methods:

  • Review of existing literature and epidemiological data on malignant mesotheliomas.
  • Analysis of etiological factors, focusing on asbestos exposure.
  • Discussion of differential diagnoses, including neoplastic and non-neoplastic lesions.

Main Results:

  • Malignant mesotheliomas are aggressive tumors with a median age of onset over 60.
  • Asbestos exposure is the primary risk factor, reported in a majority of patients.
  • Pathohistological differentiation from atypical reactive mesothelial proliferation is a significant diagnostic challenge.

Conclusions:

  • Malignant mesotheliomas require careful pathological evaluation due to diagnostic complexities.
  • Recognition of asbestos as a key etiological factor is crucial for diagnosis and compensation.
  • Accurate differentiation from benign conditions is essential for appropriate patient management.
Keywords:
AsbestosDifferential diagnosisLung dust analysisOccupational diseasePleura neoplasms

More Related Videos

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

9.7K
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.3K

Related Concept Videos

Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
752
Pleura of the Lungs01:13

Pleura of the Lungs

The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
8.1K
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
1.1K
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
863
Tissue Membranes01:27

Tissue Membranes

A tissue membrane is a thin layer of cells that covers the outside of the body, the organs, internal passageways that lead to the exterior of the body, and the lining of the moveable joint cavities. There are two basic types of tissue membranes— connective tissue and epithelial membranes.
Connective Tissue Membranes
The connective tissue membrane is formed solely from connective tissue. These membranes encapsulate organs, such as the kidneys, and line our movable joints. A synovial...
8.8K
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
4.8K